Understand the source comparison
BAC Water for Women: Comparison by Peptide Application Type
Different peptide classes require different BAC water reconstitution approaches. Female researchers studying metabolic peptides face different concentration requirements than those researching cognitive enhancers, immune modulators, or cosmetic peptides. GLP-1
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Different peptide classes require different BAC water reconstitution approaches. Female researchers studying metabolic peptides face different concentration requirements than those researching cognitive enhancers, immune modulators, or cosmetic peptides.
- GLP-1 Receptor Agonists
- Tirzepatide, Semaglutide, Retatrutide
- 10mg vial + 4mL BAC water
- 2.5mg/mL
- 0.4–1.2mL weekly
- Weight-adjusted dosing for women requires concentrations that produce drawable weekly volumes. Avoid concentrations above 5mg/mL
- Growth Hormone Secretagogues
- Ipamorelin, CJC1295, Sermorelin
- 5mg vial + 2mL BAC water
- 0.08–0.4mL daily
- Daily dosing requires multi-dose sterility. BAC water's 28-day stability is essential for protocol compliance
- Repair and Recovery Peptides
- BPC 157, TB 500, Thymosin Alpha 1
- 5mg vial + 2.5mL BAC water
- 2mg/mL
- 0.125–0.5mL daily
- Localized injection protocols benefit from lower concentrations to enable larger volumes for tissue saturation
- Cosmetic and Skin Peptides
- GHK-CU, Snap 8
- 5mg vial + 5mL BAC water
- 1mg/mL
- 0.05–0.2mL per application site
- Topical and intradermal applications require lower concentrations to avoid benzyl alcohol skin irritation
- Nootropic and Cognitive Peptides
- Semax, Selank, Dihexa
- 5mg vial + 1mL BAC water
- 5mg/mL
- 0.02–0.1mL intranasal or subcutaneous
- Intranasal delivery requires higher concentrations in smaller volumes. Benzyl alcohol at these concentrations can cause mucosal irritation
- Female researchers should adjust BAC water volumes based on study duration and dosing frequency. A 28-day stability window matters more for daily-dosed peptides (Ipamorelin, BPC 157) than weekly-dosed compounds (Tirzepatide). For weekly protocols, researchers can reconstitute smaller BAC water volumes to produce higher concentrations and smaller injection volumes. The vial will be consumed before the 28-day sterility limit.